- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03139812
Daily Irrigation With Silicone Hydrogel Contact Lens Continuous Wear (EW23)
May 1, 2017 updated by: Meng C. Lin, University of California, Berkeley
Effects of Daily Irrigation on Corneal Epithelial Permeability and Adverse Events With Silicone Hydrogel Contact Lens Continuous Wear
This study sought to determine whether daily irrigation with sterile saline solution during silicone hydrogel (SiH) contact lens continuous wear (CW) could improve ocular surface integrity and reduce the risk of adverse events.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study was to determine whether daily irrigation with sterile saline solution during silicone hydrogel (SiH) contact lens 30-day continuous wear (CW) can mitigate increases in corneal epithelial permeability (Pdc) and reduce the risk of mechanical, contact lens-induced, inflammatory, and overall adverse events.
161 non-contact lens wearers were fit with SiH contact lenses and randomized to either a treatment (n = 81) or control (n = 80) group for 30-day CW.
Subjects in the treatment group irrigated every morning and whenever dryness symptoms occurred; subjects in the control group did not.
Study Type
Interventional
Enrollment (Actual)
161
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- spectacle prescriptions between -1.00 diopter sphere (DS) and -10.00 DS;
- less than 0.75 diopters (D) of astigmatism;
- free of any ocular disease or systemic disease with ocular manifestation;
Exclusion Criteria:
- history of contact lens wear within the past year;
- history of ocular surgery or serious injury;
- presence of corneal scarring;
- frequent swimming, smoking, or use of medications w/ ocular side effects;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: 30-day SiH CW, No Daily Irrigation
Control group subjects wore SiH lenses for 30-day CW under normal clinical practice guidelines with no daily morning irrigation of the eyes with sterile saline solution
|
30-day continuous wear of silicone hydrogel contact lenses
|
OTHER: 30-day SiH CW, Daily Irrigation
Treatment group subjects wore SiH lenses for 30-day CW under normal clinical practice guidelines, and also irrigated the eyes with sterile saline solution every morning upon awakening
|
30-day continuous wear of silicone hydrogel contact lenses
Daily morning irrigation of the eye with sterile, borate-buffered, saline solution (Unisol 4) and gentle nudging of the lens to promote solution flow beneath the lens
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Corneal epithelial permeability (Pdc) at Baseline
Time Frame: Baseline
|
Rate of fluorescein clearance through the corneal epithelium, measured by scanning fluorometry, in nm/sec at baseline with no contact lenses
|
Baseline
|
Corneal epithelial permeability (Pdc) Post-1-Day CW
Time Frame: Post-1-Day CW of SiH contact lenses
|
Rate of fluorescein clearance through the corneal epithelium, measured by scanning fluorometry, in nm/sec after 1 night of contact lens CW
|
Post-1-Day CW of SiH contact lenses
|
Corneal epithelial permeability (Pdc) Post-30-Day CW
Time Frame: Post-30-Day CW of SiH contact lenses
|
Rate of fluorescein clearance through the corneal epithelium, measured by scanning fluorometry, in nm/sec after 30 nights of contact lens CW
|
Post-30-Day CW of SiH contact lenses
|
Risk of adverse events
Time Frame: Post-30-day CW of SiH contact lenses
|
Odds ratios (OR) for adverse events: contact lens-induced, mechanically-induced, inflammatory, and overall
|
Post-30-day CW of SiH contact lenses
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Meng C Lin, OD, PhD, FAAO, University of California, Berkeley
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 15, 2012
Primary Completion (ACTUAL)
October 15, 2012
Study Completion (ACTUAL)
October 15, 2012
Study Registration Dates
First Submitted
April 17, 2017
First Submitted That Met QC Criteria
May 1, 2017
First Posted (ACTUAL)
May 4, 2017
Study Record Updates
Last Update Posted (ACTUAL)
May 4, 2017
Last Update Submitted That Met QC Criteria
May 1, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UCBCRCEW23
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Epithelial Permeability
-
BrightseedRecruiting
-
Chr HansenAtlantia Food Clinical Trials; Signifikans ApSCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
University of MichiganTerminated
-
Andrasko, Gary, OD, LLCAlcon ResearchUnknownCorneal Staining | Corneal Epithelial DisruptionUnited States
-
University of FloridaOcean Spray, Inc.CompletedIntestinal Permeability | Gastrointestinal FunctionUnited States
-
Mayo ClinicCompletedImpaired Small Intestinal PermeabilityUnited States
-
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical...CompletedCorneal Epithelial DefectChina
-
Shahid Beheshti University of Medical SciencesOphthalmic Research CenterUnknownCorneal Epithelial DefectIran, Islamic Republic of
-
Trefoil Therapeutics, Inc.Completed
Clinical Trials on 30-day SiH CW
-
University of ThessalyCompleted
-
Mayo ClinicTerminatedObesityUnited States
-
University of British ColumbiaActive, not recruitingMyocardial Infarction | Atrial Fibrillation New OnsetCanada
-
Hillerod Hospital, DenmarkUnknownPhysical Activity | Acute Ischemic Stroke | AccelerometerDenmark
-
Wake Forest University Health SciencesCompletedUnplanned Hospital Readmissions | Patients at High Risk of Unplanned ReadmissionUnited States
-
Hillerod Hospital, DenmarkUnknown
-
Texas A&M UniversityUnknownCognitive Change | Nutritional Anemia | Diet, Healthy | Nutrient Deficiency | Diet; Deficiency | Visual Spatial Processing | Dietary Deficiency | Dietary B12 Deficiency | Dietary Zinc Deficiency | Dietary Vitamin B12 Deficiency Anemia | Dietary Deficiency of Selenium and Vitamin EUnited States
-
Mount Sinai Hospital, CanadaCrohn's and Colitis CanadaUnknownCrohn Disease | Ulcerative Colitis | Inflammatory Bowel DiseaseCanada
-
Health Ever Bio-Tech Co., Ltd.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaUnited States
-
University of WashingtonPatient-Centered Outcomes Research InstituteRecruiting